Norman T Ilowite

Author PubWeight™ 46.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011 3.66
2 Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008 2.56
3 The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007 2.56
4 Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012 2.21
5 Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007 2.00
6 Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 2012 1.84
7 Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2011 1.79
8 Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum 2011 1.79
9 Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009 1.56
10 Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2011 1.51
11 Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003 1.42
12 Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. Arthritis Rheum 2007 1.42
13 An i2b2-based, generalizable, open source, self-scaling chronic disease registry. J Am Med Inform Assoc 2012 1.39
14 Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum 2009 1.37
15 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum 2013 1.28
16 Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken) 2012 1.25
17 Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006 1.16
18 Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. Arthritis Rheum 2009 1.15
19 Juvenile idiopathic arthritis. Pediatr Clin North Am 2005 1.09
20 Juvenile idiopathic arthritis. Rheum Dis Clin North Am 2007 0.97
21 Comparison of the intraarticular effectiveness of triamcinolone hexacetonide and triamcinolone acetonide in treatment of juvenile rheumatoid arthritis. J Rheumatol 2004 0.89
22 Detection of active disease in juvenile idiopathic arthritis: sensitivity and specificity of the physical examination vs ultrasound. J Rheumatol 2011 0.88
23 Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2014 0.87
24 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res (Hoboken) 2013 0.86
25 Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis 2013 0.86
26 Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis. Arthritis Rheum 2010 0.85
27 Panniculitis, infection, and dermatomyositis: case and literature review. Clin Rheumatol 2009 0.84
28 Using registries to identify adverse events in rheumatic diseases. Pediatrics 2013 0.83
29 Response of systemic onset juvenile rheumatoid arthritis to etanercept: is the glass half full or half empty? J Rheumatol 2005 0.81
30 Systemic lupus erythematosus in children and adolescents. Pediatr Rev 2006 0.80
31 Giant coronary artery aneurysms in juvenile polyarteritis nodosa: a case report. Pediatr Rheumatol Online J 2012 0.79
32 Prevalence of annexin A5 resistance in children and adolescents with rheumatic diseases. J Rheumatol 2011 0.78
33 Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project. Arthritis Care Res (Hoboken) 2015 0.77
34 Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives. Expert Opin Pharmacother 2013 0.77
35 Cranial nerve involvement with juvenile polyarteritis nodosa: clinical manifestations and treatment. Pediatrics 2010 0.76
36 Pediatric rheumatic disease: Vaccination in pediatric rheumatic disease--risks and benefits. Nat Rev Rheumatol 2012 0.76
37 A dose schedule for intraarticular steroids in juvenile arthritis. J Rheumatol 2011 0.75
38 Ultrasound and cartilage thickness in juvenile idiopathic arthritis: new findings, new questions. J Rheumatol 2013 0.75
39 Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood. J Pediatr 2011 0.75
40 Panniculitis and lipodystrophy. Curr Opin Rheumatol 2002 0.75
41 Flares in pediatric systemic lupus erythematosus. J Rheumatol 2007 0.75
42 Systemic juvenile idiopathic arthritis: a review. Pediatr Ann 2012 0.75
43 Novel treatment options for juvenile idiopathic arthritis. Expert Rev Clin Pharmacol 2015 0.75
44 Treatment of rheumatic diseases in children: special considerations. Rheum Dis Clin North Am 2002 0.75
45 Wasabi nose: an underreported complication of cyclophosphamide infusions. Clin Rheumatol 2011 0.75